SP

Sabita Padhi

Active Director Additional Director DIN 09490458
DIN 09490458 First appointment Jan 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Sabita Padhi

Data last updated:

Sabita Padhi is an Additional Director at Parasmoni Healthcare Private Limited (since 2022). The company operates in Healthcare.

DIN 09490458
Primary Designation Additional Director
Industry Healthcare
First Appointment 06 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parasmoni Healthcare Private Limited U85100WB2021PTC249749
Additional Director06 Jan 20222021Active

Directorship timeline

Open interactive timeline →
Parasmoni Healthcare Private Limited
Premium access

Shareholding and investment profile for Sabita Padhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sabita Padhi

Sabita Padhi currently holds 1 directorship: Parasmoni Healthcare Private Limited (Additional Director, since 06 Jan 2022).

Sabita Padhi was first appointed on 06 Jan 2022 as Additional Director at Parasmoni Healthcare Private Limited.

The current boards of Sabita Padhi's companies include Arnab Sasmal (Parasmoni Healthcare Private Limited), Himadri Mondal (Parasmoni Healthcare Private Limited), Monalisa Giri Paria (Parasmoni Healthcare Private Limited), Satya Ranjan Giri (Parasmoni Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available